A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages 1051-1059

  Farasat, Sharifeh ^a   Yu, Siegrid S ^d   Neel, Victor A ^e   Nehal, Kishwer S ^f   Lardaro, Thomas ^a   Mihm, Martin C ^e   Byrd, David R ^g   Balch, Charles M ^a,b   Califano, Joseph A ^c   Chuang, Alice Y ^b   Sharfman, William H ^b   Shah, Jatin P ^f   Nghiem, Paul ^h   Otley, Clark C ⁱ   Tufaro, Anthony P ^b   Johnson, Timothy M ^j   Sober, Arthur J ^e   Liégeois, Nanette J ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

more..

Author keywords

American Joint Committee on Cancer staging system; anatomic site; cutaneous squamous cell carcinoma; depth of tumor; high risk tumor features; histopathologic grade or differentiation; perineural invasion; prognosis; skin cancer; staging criteria; tumor diameter

Indexed keywords

AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RISK; CANCER STAGING; CONSENSUS; EYELID CARCINOMA; HEAD AND NECK CANCER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; PERINEUM; PRIORITY JOURNAL; SKIN CARCINOMA; SKULL; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS;

EID: 79956069912     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.08.033     Document Type: Article

References (56)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002;146(Suppl):1-6.
2. Ramos J, Villa J, Ruiz A, Armstrong R, Matta J. UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2006-11. (Pubitemid 40054293)
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
4. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001;344:975-83. (Pubitemid 32240317)
5. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90.
6. Dinehart SM, Peterson S. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005;31:1379-84.
7. Talmi YP. Problems in the current TNM staging of nonmelanoma skin cancer of the head and neck. Head Neck 2007;29:525-7. (Pubitemid 47324767)
8. Palme CE, MacKay SG, Kalnins I, Morgan GJ, Veness MJ. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007;15:103-6. (Pubitemid 46594862)
9. Chapter 29: Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, et al, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
10. Chapter 23: Carcinoma of the skin (excluding eyelid, vulva, and penis). In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al, editors. AJCC cancer staging manual. 6th ed. Chicago: Springer; 2002.
11. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998;78:587-93. (Pubitemid 28507182)
12. Chuang TY, Popescu NA, Su WP, Chute CG. Squamous cell carcinoma: a population-based incidence study in Rochester, Minn. Arch Dermatol 1990;126:185-8. (Pubitemid 20055687)
13. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology 1994;189:52-4. (Pubitemid 24126372)
14. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997;79:915-9. (Pubitemid 27089874)
15. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002;28:268-73. (Pubitemid 34259756)
16. Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer 2006;106:2389-96. (Pubitemid 43787663)
17. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007;29:621-31. (Pubitemid 47168232)
18. Veness MJ. High-risk cutaneous squamous cell carcinoma of the head and neck. J Biomed Biotechnol 2007;2007:80572.
19. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007;33:885-99. (Pubitemid 47106729)
20. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990;94:624-7. (Pubitemid 20369727)
21. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip: an analysis of twenty-seven cases. J Am Acad Dermatol 1989;21:241-8. (Pubitemid 19195886)
22. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998;124:582-7. (Pubitemid 28222350)
23. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006;13:902-9.
24. Quaedvlieg PJ, Creytens DH, Epping GG, Peutz-Kootstra CJ, Nieman FH, Thissen MR, et al. Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips. Histopathology 2006;49:256-64. (Pubitemid 44253615)
25. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005;23:759-65. (Pubitemid 46237442)
26. Rodolico V, Barresi E, Di Lorenzo R, Leonardi V, Napoli P, Rappa F, et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumor size, histologic variables and p27Kip1 protein expression. Oral Oncol 2004;40:92-8.
27. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:1561-7. (Pubitemid 41330662)
28. Daniele E, Rodolico V, Leonardi V, Tralongo V. Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors. Pathol Res Pract 1998;194:319-24. (Pubitemid 28291368)
29. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91. (Pubitemid 36459475)
30. Khanna M, Fortier-Riberdy G, Smoller B, Dinehart S. Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol 2002;29:321-3.
31. Dinehart SM, Nelson-Adesokan P, Cockerell C, Russell S, Brown R. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997;79:920-3. (Pubitemid 27089875)
32. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985;56:1099-105. (Pubitemid 15003494)
33. Johnson RE, Ackerman LV. Epidermoid carcinoma of the hand. Cancer 1950;3:657-66.
34. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002;24:417-22. (Pubitemid 34506700)
35. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003;113:1827-33. (Pubitemid 37210989)
36. Palme CE, O'Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003;129:750-3. (Pubitemid 36858963)
37. Audet N, Palme CE, Gullane PJ, Gilbert RW, BrownDH, Irish J, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck 2004;26:727-32. (Pubitemid 39014638)
38. Andruchow JL, Veness MJ, Morgan GJ, Gao K, Clifford A, Shannon KF, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006;106:1078-83.
39. Ch'ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis - an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg 2006;59:1288-93.
40. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999;85:1758-64. (Pubitemid 29169677)
41. Preciado DA, Matas A, Adams GL. Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head Neck 2002;24:319-25. (Pubitemid 34260033)
42. Martinez JC, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003;139:301-6. (Pubitemid 36330577)
43. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008;9:713-20.
44. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984;148:542-7.
45. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II: perineural invasion. J Am Acad Dermatol 2005;53:261-6. (Pubitemid 40979583)
46. Fagan JJ, Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:637-40. (Pubitemid 28272928)
47. Garcia-Serra A, Hinerman RW, Mendenhall WM, Amdur RJ, Morris CG, Williams LS, et al. Carcinoma of the skin with perineural invasion. Head Neck 2003;25:1027-33. (Pubitemid 37475265)
48. Lawrence N, Cottel WI. Squamous cell carcinoma of skin with perineural invasion. J Am Acad Dermatol 1994;31:30-3. (Pubitemid 24198158)
49. Feasel AM, Brown TJ, Bogle MA, Tschen JA, Nelson BR. Perineural invasion of cutaneous malignancies. Dermatol Surg 2001;27:531-42. (Pubitemid 32552906)
50. Broders AC. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg 1921;73:141-60.
51. Mohs FE. Chemosurgery: microscopically controlled surgery for skin cancer. Springfield (IL): Charles C. Thomas; 1978.
52. Eroglu A, Berberoglu U, Berreroglu S. Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol 1996;61:124-30. (Pubitemid 26066072)
53. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000;143:1224-9.
54. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9. (Pubitemid 19034033)
55. Penn I. Malignancy. Surg Clin North Am 1994;74:1247-57.
56. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-86. (Pubitemid 29072794)